My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Biodelivery Sciences International (BDSI)
NASDAQ:BDSI
BDSI nasdaq
United States
BioDelivery

BioDelivery Stock Analysis & Ratings

BioDelivery Stock Analysis Overview

Smart Score
6
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The BioDelivery stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

BDSI

BDSI Stock Stats

Previous Close$2.78
Open$2.78
Bid2.73 x 3100
Ask2.86 x 100
Today’s Range$2.69 - $2.85
52-Week Range$2.69 - $4.99
Volume1.05M
Average Volume915.00K
Market Cap$267.74M
Beta0.84
P/E Ratio9.3
EPS0.30
Earnings DateMar 17, 2022

Company Description

Biodelivery Sciences International

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded in 1997 and is headquartered in Raleigh, NC.
Sector
Healthcare
Industry
Drug Manufacturers
CEO
Jeffrey Allen Bailey
Employees
176
ISIN
US09060J1060
Address
4131 ParkLake Avenue, Raleigh, NC, 27612, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

BDSI FAQ

What was BioDelivery’s price range in the past 12 months?
BioDelivery lowest stock price was $2.69 and its highest was $4.99 in the past 12 months.
    What is BioDelivery’s market cap?
    BioDelivery’s market cap is $267.74M.
      What is BioDelivery’s price target?
      The average price target for BioDelivery is $6.88. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $10.00 ,the lowest forecast is $4.50. The average price target represents 153.87% Increase from the current price of $2.71.
        What do analysts say about BioDelivery?
        BioDelivery’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is BioDelivery’s upcoming earnings report date?
          BioDelivery’s upcoming earnings report date is Mar 17, 2022 which is in 105 days.
            How were BioDelivery’s earnings last quarter?
            BioDelivery released its earnings results on Nov 03, 2021. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.055 by $0.015.
              Is BioDelivery overvalued?
              According to Wall Street analysts BioDelivery’s price is currently Undervalued.
                Does BioDelivery pay dividends?
                BioDelivery does not currently pay dividends.
                What is BioDelivery’s EPS estimate?
                BioDelivery’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does BioDelivery have?
                BioDelivery has 98,800,000 shares outstanding.
                  What happened to BioDelivery’s price movement after its last earnings report?
                  BioDelivery reported an EPS of $0.07 in its last earnings report, beating expectations of $0.055. Following the earnings report the stock price went down -16.381%.
                    Which hedge fund is a major shareholder of BioDelivery?
                    Among the largest hedge funds holding BioDelivery’s share is Deerfield Management Company, LP. It holds BioDelivery’s shares valued at 33M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis